CEC Capital Group serves as exclusive financial advisor for this transaction

Shenzhen Fussen Technology Co., Ltd. (hereinafter referred to as "Dentalink" or the “Company”), a leader in the Chinese domestic digital dental industry and a provider of digital dental solutions, recently announced the completion of a Series C financing of hundreds of millions of RMB. The financing round was led by Sequoia Capital China, with CICC, CBD Capital, Qianhai Fund of Funds, Ping An Ventures, and other new and existing shareholders participating as followers.

CEC Capital Group served as exclusive financial advisor to Dentalink in this transaction.

The success of this financing demonstrates the recognition that top-tier funds have for leading domestic digital dental companies with global growth potential, and also highlights CEC Capital Group’s market-leading position as an advisor on financing transactions in the digital medical and dental space.

Dentalink was established in 2010. The Company combines digital imaging equipment, a SaaS platform, and other digital software and hardware to create its digital dental platform. Their platform connects upstream and downstream participants in the industry, providing data, value-added services, and a 3D dental design platform to players in the industry. The Company is also in the process of realizing additional oral products solutions (e.g., planting, orthodontics, aesthetics, etc.) and is building an industry-leading digital oral marketplace.

Presently, Dentalink has three core businesses that are in leading positions in the oral care industry. The Company’s oral digital imaging equipment sales network covers 29 provinces and cities across China, with 100+ contracted agents and an active overseas sales network. Their dental SaaS tool covers 80,000 dental clinics in more than 400 cities, and holds a 50% market share in dental specialist hospitals, and a 30% market share in large-scale dental chains. The Company’s performance in the small and medium outpatient market, and other core indicators such as retention, share, and active users are also well ahead of the rest of the industry. Finally, their consumables supply system was launched in early 2018, and now serves over 20,000 customers, helping lay the framework for a new digital oral marketplace.

After this round of financing, Dentalink aims to accelerate the mergers and acquisitions of upstream and downstream industry participants. The Company also plans to push the development of its digital design platforms, expand the coverage of digital software and hardware facilities from oral cavity to consumer end-product solutions, and build out its digital platform throughout the entire industry chain.

About Sequoia Capital

Sequoia Capital is committed to helping entrepreneurs build long-lasting companies, by bringing together extensive global resources and experience to its portfolio companies. Over the past 48 years, Sequoia Capital has invested in many innovative companies and industry trendsetters. Sequoia Capital China, as the "entrepreneur behind the entrepreneur", focuses on investment opportunities in four areas: technology/media, healthcare, consumer goods/services, and industrial technologies. Over the past 15 years, Sequoia Capital China has invested into nearly 600 companies with unique technologies, innovative business models, and high growth potential.

About CEC Capital Group

Founded in 2000, CEC Capital Group is one of China’s leading investment banks focusing on the three major industries of healthcare, consumer, and TMT. The company is headquartered in Beijing, with offices in Shanghai. Its US affiliate, China eCapital Partners, LLC, has offices in Los Angeles and San Francisco.

In the three years from 2017 to 2019, CEC Capital Group has participated in financing and M&A transactions valued at a total of more than RMB 100 billion. In addition to its investment banking business, CEC Capital Group has been managing an RMB fund and a USD fund since 2014.

CEC Capital Group has the healthcare industry’s largest dedicated investment banking coverage team in China, with comprehensive coverage of the entire ecosystem and a market-leading position in the industry. The firm has advised on the largest number of healthcare-related private capital financing transactions over the past three years among China-based investment banks.